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Abstract
Sleep duration varies widely across individuals and appears to be trait-like. Differences in
the stability of underlying sleep processes may underlie this phenomenon. To investigate
underlying mechanisms, we examined the relationship between sleep duration and sleep
continuity in baseline polysomnography (PSG) recordings from three independently col-
lected datasets: 1) 134 healthy controls (ages 37 ± 13 years) from the São Paulo Epidemio-
logic Sleep Study, who spent one night in a sleep laboratory, 2) 21 obstructive sleep apnea
(OSA) patients who were treated with continuous positive airway pressure for at least 2
months (45 ± 12 years, respiratory disturbance index <15), who spent one night in a sleep
laboratory with previous experience of multiple PSG studies, and 3) 62 healthy controls (28
± 6 years) who, as part of larger experiments, spent 2 consecutive nights in a sleep labora-
tory. For each dataset, we used total sleep time (TST) to separate subjects into those with
shorter sleep (S-TST) and those with longer sleep (L-TST). In all three datasets, survival
curves of continuous sleep segments showed greater sleep continuity in L-TST than in S-
TST. Correlation analyses with TST as a continuous variable corroborated the results; and
the results also held true after controlling for age. There were no significant differences in
baseline waking performance and sleepiness between S-TST and L-TST. In conclusion, in
both healthy controls and treated OSA patients, sleep continuity was positively correlated
with sleep duration. These findings suggest that S-TST may differ from L-TST in processes
underlying sleep continuity, shedding new light on mechanisms underlying individual differ-
ences in sleep duration.
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Introduction
According to the two-process model of sleep regulation [1, 2], sleep duration is regulated by
the interaction of two physiological processes: a circadian process tracking time of day, and a
homeostatic process tracking time awake and time asleep. The circadian process is rhythmic
with a period of (approximately) 24 hours, and is driven by the circadian pacemaker in the
suprachiasmatic nuclei. The homeostatic process involves a saturating exponential increase of
sleep pressure during time awake, and a saturating exponential decrease of sleep pressure dur-
ing time asleep. The exponential nature of the dissipation of sleep pressure implies that it dissi-
pates faster—more “efficiently”–when it is higher.
Among normal sleepers, sleep duration varies widely across individuals in a trait-like man-
ner [3]. Twin studies based on self-report have revealed that individual differences in sleep
duration may have a genetic basis [4, 5]. Evidence from laboratory studies of sustained sleep
restriction or sleep extension has suggested that being a short or long sleeper may also result
from changes in the set point of the homeostatic process due to chronic prior sleep curtailment
[6]. Laboratory studies have also shown physiological differences between short sleepers and
long sleepers [7–10]. In particular, sleep deprivation and sleep extension studies in carefully
screened “true” short sleepers and “true” long sleepers, who were operationally defined as habit-
ually sleeping less than 6 hours per night and more than 9 hours per night, respectively, have
provided evidence that “true” short sleepers live under a higher homeostatic sleep pressure than
“true” long sleepers [8, 9]. The “true” short sleepers had a higher sleep efficiency (total sleep
time [TST] / time in bed [TIB]) than the “true” long sleepers [8]. In the context of the two-pro-
cess model of sleep regulation, the better sleep efficiency of short sleepers is compatible with the
idea that short sleepers live under a higher homeostatic sleep pressure than long sleepers.
In apparent contrast, data of healthy people from a general population study in Pennsylvania
[11] and from a community-based study in Hong Kong [12] not selected for extreme TST sug-
gest that those with shorter TST may have a lower sleep efficiency than those with longer TST.
Consistent with this is the finding that 24-hour norepinephrine and epinephrine levels are
inversely correlated to sleep efficiency and higher in shorter sleepers than in longer sleepers
[12]. Higher norepinephrine and epinephrine levels indicate greater sympathetic activity, which
is associated with increased wakefulness or arousal, and may lead to less stable sleep in shorter
sleepers [13–15]. Even if these disparate findings can be reconciled, it remains to be explained
why short sleepers would maintain a higher homeostatic sleep pressure given that their greater
sleep efficiency should allow them to reduce that pressure highly efficiently [2, 8, 9].
Analysis of dynamic aspects of sleep has elucidated novel properties of sleep regulation [16–
18]. Measures of sleep continuity [19, 20], which capture the dynamics of sleep—wake transi-
tions, have been shown to provide useful information beyond traditional sleep variables [21,
22]. For instance, survival curve (i.e., cumulative duration distribution) analysis of continuous
sleep segments has revealed a difference in sleep continuity between patients with mild
obstructive sleep apnea/hypopnea syndrome and controls, where traditional sleep variables
such as TST and sleep efficiency did not detect any difference [20]. Other analyses of sleep—
wake dynamics have shown that older people have more trouble maintaining continuous sleep
(specifically non-REM sleep) compared to younger people [23, 24].
In the present study, we analyzed sleep—wake dynamics to investigate the relationship
between sleep duration and sleep continuity in baseline polysomnography (PSG) records from
three previously collected laboratory datasets: 1) healthy controls from the São Paulo Epidemi-
ologic Sleep Study [25], who spent one night in a sleep laboratory, 2) obstructive sleep apnea
(OSA) patients treated with and adherent to continuous positive airway pressure (CPAP) for
at least 2 months [26], who spent one night in a sleep laboratory with previous experience of
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multiple PSG studies, and 3) healthy young adult controls who, as part of larger experiments,
spent 2 consecutive nights in a sleep laboratory [3, 27–30].
Methods
Subjects and study protocols
Laboratory-based nocturnal PSG (NPSG) recordings and subjective and/or objective measures
of sleepiness and fatigue from three previously collected datasets were examined. The three
datasets were similar in that subjects were included in the analysis only when they had no
known sleep pathology (except for the second group having treated OSA), no subjective sleep
complaints, and normal sleep-wake schedule. For all datasets, baseline NPSG recordings were
collected and sleep stages were scored manually according to the original [21] standard criteria
or the American Academy of Sleep Medicine (AASM) [22] for the investigation of sleep. The
hypnogram and age data for all subjects in all datasets are included in the S1 File.
Dataset 1: São Paulo controls. The subjects in this dataset were 134 subjects (68 men and
66 women, aged 37 ± 13 years [range: 20–78 years], body mass index [BMI]: 25 ± 5) free from
sleep abnormalities, taken from the São Paulo Epidemiologic Sleep Study [25]. In the parent
study, a three-stage cluster sampling technique with unequal selection probability was used to
obtain a representative sample of the inhabitants of São Paulo, Brazil, according to gender, age
(20–80 years) and socioeconomic status, excluding shift workers. For the parent cohort, a total
of 1,042 subjects underwent one NPSG at the Sleep Institute in São Paulo. The study was
approved by the Ethics Committee for Research of the Universidade Federal de São Paulo /
Hospital São Paulo, and all subjects gave written informed consent.
From the parent study, we selected all subjects who had no discernable sleep or pulmonary
disorder or complaints, that is, who met the following criteria:
1. No known diagnosis of a sleep disorder or sleep complaints, including specifically, no
excessive daytime sleepiness (EDS) as evidenced by an Epworth Sleepiness Scale (ESS) [31]
score10, no fatigue as evidenced by a Chalder Fatigue Scale (CFS) [32] score4, and no
witnessed apneas reported on a sleep questionnaire [33].
2. No NPSG-assessed OSA, defined as an apnea/hypopnea index (AHI4%) < 5 [34].
3. No significant primary lung disease, as evidenced by a respiratory questionnaire validated
by the American Thoracic Society [35].
Dataset 2: Treated OSA patients. The subjects in this dataset were 21 OSA patients (15
men and 6 women, aged 45 ± 12 years [range: 21–65 years], BMI: 38 ± 11), selected from a
larger study based on compliance with CPAP for at least 2 months. The parent study involved
OSA patients aged 18 years or older, prospectively recruited from all patients seen at the New
York University (NYU) Sleep Disorders Center between 2006 and 2009 initially presenting
with complaints of EDS and/or snoring, a NPSG showing a respiratory disturbance index (RDI;
total number of apneas, hypopneas and flow-limitation events per hour of sleep) [36]>10/
hour, prolonged periods of inspiratory flow limitation or REM-related and/or supine RDI>15/
hour, and eligible for a clinical trial of CPAP per the treating sleep physician. Subjects who were
pregnant or had medically unstable conditions, congestive heart failure, a change in medica-
tions during the trial, or history of alcohol or recreational drug abuse were excluded.
As part of the parent study, patients underwent a full-night manual laboratory CPAP titra-
tion study performed by an experienced sleep technician according to the AASM guidelines
[37], where pressure was raised until all obstructive apneas, hypopneas, and runs of inspiratory
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flow limitation were eliminated to obtain a single, optimal pressure. Patients were given a cus-
tom CPAP machine (Fisher & Paykel HealthCare, New Zealand) with enhanced adherence
monitoring capability to use at home. All patients had heated humidification but did not
receive bilevel pressure, expiratory pressure relief or a pressure ramp.
Adherence to CPAP use was confirmed with downloaded data for at least 14 days after a
minimum of 4 weeks of successful therapy. After an average of 9 weeks of therapy (range 6
weeks to 3 months), laboratory NPSG data were collected—these are the data used in this
paper. The study was approved by NYU School of Medicine Institutional Review Board, and
all patients gave written informed consent. Only those subjects with documented adherence
of>4 hours/night (mean ± SD; 6 ± 1 hours) and an ESS score10 on therapy were included
in the present analysis.
Dataset 3: Healthy young adult controls. The subjects in this dataset were 62 healthy
controls (24 men and 38 women, aged 28 ± 6 years [range: 22–40 years], BMI: 26 ± 5). Data
were taken from baseline PSG measurements made in 5 different laboratory sleep deprivation
experiments [3, 27–30]. In each experiment, subjects lived in a laboratory and underwent 2
successive baseline NPSG recordings prior to any other manipulations. Both baseline NPSGs
were used for the present analyses.
All subjects were physically and psychologically healthy as assessed by questionnaires, phys-
ical exam and history, blood chemistry and urinalysis. They reported being good sleepers with
regular bedtimes and wake-up times. Subjects were included if they had habitual sleep dura-
tions between 7 and 9 h per night [3, 27] or between 6 and 10 h per night [28–30] and habitu-
ally woke up between 06:30 and 08:30 [3, 27] or between 06:00 and 09:00 [28–30]. Habitual
sleep duration and wake-up time were verified by wrist actigraphy and sleep diaries in the 7
days preceding the laboratory experiments. Subjects had no history of alcohol or drug abuse.
They refrained from using drugs, alcohol, tobacco, and caffeine 7 days prior to and during the
experiment and were not allowed to take any naps during this period. The Institutional Review
Boards of the University of Pennsylvania and/or Washington State University approved the
studies, and all subjects gave written informed consent.
Polysomnography
Dataset 1: São Paulo controls. The full-night in-laboratory NPSG recordings were per-
formed using a digital system (Embla S7000, Embla Systems, Inc., Broomfield, CO, USA). The
recording protocol required subjects to abide by their usual bedtimes and wake-up times,
where their schedule was verified by an actigraph and sleep diary filled out for at least 72
hours. The NPSG recordings were started between 21:30 and 02:30, and TIB was between 4.5
and 10 hours.
The following physiological variables were monitored simultaneously and continuously at a
sampling rate of 256 Hz: four electroencephalogram (EEG) derivations, C3-A2, C4-A1,
O1-O2, O2-A1; two electrooculogram (EOG) derivations, LOC-A2, ROC-A1; four surface
electromyogram (EMG) derivations, submental, anterior tibialis muscle, masseter region, and
seventh intercostal muscles; one electrocardiogram (ECG) channel, modified V2 derivation;
airflow detected by oronasal thermocouple and nasal cannula pressure (50 Hz); two channels
for “X-trace” belts, which record respiratory effort of the thorax and of the abdomen; channels
for snoring and body position, using Embla sensors; one channel for arterial oxygen saturation
(SpO2); and one channel for pulse rate recorded by means of a built-in Embla oximeter.
Sleep stages, arousals and leg movements were scored manually according to the AASM
standard criteria for the investigation of sleep [22]. Apneas were scored and classified follow-
ing the AASM 2007 recommended respiratory rules for adults [22], i.e., when there was a drop
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in the airflow amplitude of> 90% of baseline lasting10 s. Hypopneas were scored by the
“Chicago” criteria [38], i.e., when there was a discernable reduction in airflow amplitude on
the nasal cannula signal lasting10 s and accompanied by a decrease of3% in SpO2 or an
EEG arousal.
Dataset 2: Treated OSA patients. The post-treatment-initiation, in-laboratory NPSG
recordings were performed using the Sandman sleep system (Embla Systems, Inc., Broomfield,
CO, USA) while subjects slept wearing their usual nasal CPAP. Lights out and end of study
were determined by patient report of usual sleep times. The NPSG recordings were started
between 21:00 and 00:05, and TIB was between 7.9 and 11 hours.
The following physiological variables were monitored simultaneously and continuously
at a sampling rate of 256 Hz: four EEG derivations, C3-M2, C4-M1, O1-M2, Fz-M2; two
EOG derivations, LOC-M2, ROC-M1; chin and leg EMG; lead II ECG; rib and abdomen
movement by respiratory inductance plethysmography; respiratory airflow from the CPAP
analog output; and finger pulse oximetry. All sleep studies were scored manually for sleep
and respiration by experienced technicians according to the AASM standard criteria for the
investigation of sleep [22].
Dataset 3: Healthy young adult controls. The two baseline NPSG recordings were made
with digital equipment (Vitaport 3, TEMEC Instruments, Kerkrade, The Netherlands or
Nihon Kohden, Foothill Ranch, CA, USA). The NPSG recordings were started at 22:00 and
TIB was fixed at 10 hours [28–30] or 12 hours [3, 27] depending on the experiment. For equiv-
alence between studies in this dataset, only the first 10 hours of PSG data were analyzed for the
experiments with 12 hours TIB.
The following physiological variables were monitored simultaneously at a sampling rate of
128 Hz [3] or 200 Hz [27–30]: four or six EEG derivations, C3-Ax, C4-Ax, Fz-Ax, Oz-Ax
(where Ax stands for bridged mastoids) [3, 27] or C3-M2, C4-M1, Fz-M2, Oz-M1 [28] or
F3-M2, F4-M1, C3-M2, C4-M1, O1-M2, O2-M1 [29, 30]; two derivations for EOG, LOC-Ax,
ROC-Ax [3, 27] or E1-M2, E2-M1 [28–30]; chin EMG, submentalis; and ECG, modified lead
II [3, 27] or left versus right sub-clavicle [28–30]. Sleep stages were scored manually by a regis-
tered PSG technologist according to the original [21] standard criteria [3, 27] or the new
AASM [22] standard criteria [28–30] for the investigation of sleep.
Measurement of sleepiness and fatigue
Dataset 1: São Paulo controls. Subjective sleepiness and fatigue were assessed using the
ESS [31] and CFS [32]. ESS is an 8-item questionnaire assessing a person’s expectation of fall-
ing asleep in different circumstances. CFS is a 14-item questionnaire measuring symptoms of
physical and mental fatigue. After the PSG study, subjects were asked about their quality of
sleep and rated it as “better,” “the same” or “worse” than usual.
Dataset 2: Treated OSA patients. Subjective sleepiness was assessed using the ESS [31].
Objective sleepiness was measured with the Multiple Sleep Latency Test (MSLT) [39] and a
20-minute psychomotor vigilance test (PVT) [40]. The MSLT is a PSG-based technique involv-
ing 20-minute sessions in which sleep latency is measured as an objective index of physiologi-
cal sleepiness. The PVT is a serial reaction time test that measures sustained attention as an
index of behavioral alertness. These tests were administered 4 times at 2-hour intervals begin-
ning at 09:00. Mean MSLT sleep latency and mean PVT lapses (number of reaction
times> 500 ms) were calculated as the average over the 4 tests.
Dataset 3: Healthy young adult controls. Subjective sleepiness was assessed using the
ESS [31]. Objective sleepiness was measured with a 10-minute PVT [40] administered at
2-hour intervals during scheduled wakefulness on the day after the first NPSG.
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Data analyses
Data reduction. Each dataset was dichotomized into shorter TSTs (S-TST) and longer
TSTs (L-TST) depending on whether their TST was below or above a study-specific threshold.
For dataset 1 (São Paulo controls) and dataset 2 (Treated OSA patients), in which subjects fol-
lowed their usual bedtimes and wake-up times, the study-specific median TST was used as a
cut point. For dataset 3 (Healthy young adult controls), in which subjects were given 10 or 12
hours TIB, TST was markedly longer, and the first tertile value of the TST distribution was
used as a cut point for defining S-TST and L-TST. Additional analyses were performed using
the same TST cut point, specifically the median TST of all subjects of all datasets, for all data-
sets with the data combined and for each dataset separately (see details in S2 File). The data
from the first and second nights in dataset 3 were analyzed separately. In secondary analyses,
within-subjects comparisons were made between the two NPSGs from dataset 3.
Sleep continuity was examined by generating a nonparametric survival curve of the dura-
tions of continuous sleep segments, defined as consecutive epochs scored as sleep (non-REM
and/or REM) terminated by one or more epochs scored as wakefulness. Survival curves were
generated for the pooled data of each dataset separately (and analyzing nights 1 and 2 of data-
set 3 separately as well) using the whole-night hypnogram. The median, 25th percentile and
75th percentile durations of continuous sleep segments were also calculated for each individual
subject. Survival curves were also generated for the first 3 hours of the hypnogram (datasets 1
and 3; this could not be done for dataset 2 because of insufficient number of sleep segments) to
see whether results were robust to analysis timeframe. Similarly, the continuity of wakefulness
during the sleep period was examined by generating a nonparametric survival curve of the
durations of continuous wake segments, defined as consecutive epochs scored as wakefulness
terminated by one or more epochs scored as sleep.
Statistical analyses. For each of the datasets separately (and for days 1 and 2 of dataset 3
separately), Mann-Whitney U tests were used to compare S-TST versus L-TST for PSG-
assessed sleep variables, subjective and objective measures of sleepiness and fatigue, age, and
BMI. For dataset 3, Wilcoxon signed-rank tests were used to compare the first night with the
second night for PSG-assessed sleep variables. χ2 tests for independence were used to compare
S-TST versus L-TST with regard to the distribution of males and females, and in dataset 1 for
the question about subjective sleep quality (comparison to “usual”). Generalized Wilcoxon tests
[41] were used to compare S-TST versus L-TST on the survival curves. Spearman’s ρ was used
to examine relationships between TST as a continuous variable and median duration of contin-
uous sleep segments—both across all datasets (controlling for study and age) and in each data-
set separately. To investigate the stability of categorizing subjects as S-TST or L-TST based on
TST in dataset 3 (where two consecutive nights were recorded), we calculated the intraclass cor-
relation coefficient (ICC) [42] for TST. We also performed this analysis for median duration of
continuous sleep segments. The ICC was derived from a mixed-effects analysis of variance
(ANOVA) with a random effect on the intercept and covariates for night number and study.
Results
Demographics and traditional sleep variables
Table 1 compares age, sex, BMI, and traditional sleep variables between the S-TST and L-TST
groups. Within each dataset, age, sex and BMI did not differ significantly between the two
groups.
The distribution of TST in each dataset is shown in Fig 1. The medians of TST for dataset 1
(São Paulo controls) and for dataset 2 (Treated OSA patients) were 334.3 min and 442.5 min,
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respectively. For dataset 3 (Healthy young adult controls), the first tertile values for the first
and the second nights were 503.3 min and 515.6 min, respectively. These values were used to
separate subjects into S-TST and L-TST groups for each night. For dataset 3, 68% of subjects
remained in the same group across the two nights of PSG (note that our analyses were not con-
tingent on stability of group assignment).
For all datasets (and for both nights of dataset 3), sleep efficiency was significantly less in
S-TST than in L-TST, and percentage of wakefulness after sleep onset (WASO) was signifi-
cantly greater in S-TST than in L-TST (Table 1). For dataset 1 and for both nights of dataset 3,
percentages of N2 and REM sleep were significantly less in S-TST than in L-TST. For both
nights of dataset 3, sleep latency was significantly longer in S-TST than in L-TST. For the first
night only, REM latency was significantly longer in S-TST than in L-TST. Taken together,
these results suggest that sleep architecture was different between S-TST and L-TST and, nota-
bly, that sleep was more consolidated in L-TST than in S-TST. For dataset 3, none of the sleep
variables differed significantly between the first and second nights.
Table 1. Characteristics of subjects, sleep variables, sleep continuity and measures of sleepiness and fatigue for all datasets.
Dataset 1 Dataset 2 Dataset 3
1st night 2nd night
S-TST L-TST S-TST L-TST S-TST L-TST S-TST L-TST
Number of subjects 67 67 10 11 21 41 21 41
% Men 47.8 53.7 80.0 63.6 38.1 39.0 23.8 46.3
Age (years) 39.1 ± 12.7 34.8 ± 12.8 50.2 ± 9.8 41.0 ± 13.4 26.6 ± 4.1 29.5 ± 6.0 27.8 ± 5.9 28.1 ± 5.3
Body mass index (kg/m2) 25.6 ± 5.8 24.4 ± 4.1 35.5 ± 10.9 40.3 ± 11.4 25.6 ± 4.5 24.7 ± 3.5 27.5 ± 4.0 24.7 ± 4.4
Sleep structure
Time in Bed (min) 355.9 ± 48.7 434.5 ± 63.0** 521.3 ± 31.8 538.9 ± 44.5 599.8 ± 0.4 599.8 ± 0.5 599.8 ± 0.7 599.8 ± 0.7
Total Sleep Time (min) 270.2 ± 56.1‡ 378.0 ± 45.2‡ 382.3 ± 89.7‡ 477.2 ± 28.8‡ 460.6 ± 38.7‡ 544.0 ± 19.5‡ 459.9 ± 42.7‡ 540.5 ± 17.2‡
Sleep Efficiency (%) 76.7 ± 16.5 88.2 ± 8.1** 73.8 ± 18.4 88.9 ± 6.5** 76.8 ± 6.4 90.7 ± 3.3** 76.7 ± 7.1 90.1 ± 2.9**
Wakefulness After Sleep Onset (%) 16.3 [8.8–23.5] 10.2 [4.4–14.1]** 14.9 [13.2–22.3] 6.3 [4.6–9.4]** 15.2 [12.0–20.5] 6.1 [3.7–9.6]** 16.0 [8.5–21.0] 5.9 [4.0–8.2]**
N1 (%) 3.2 [2.2–5.2] 2.6 [1.6–4.1] 12.1 [10.7–13.5] 11.3 [9.7–14.0] 4.5 [3.6–5.9] 4.5 [3.4–5.9] 4.8 [3.4–6.5] 4.0 [3.0–6.0]
N2 (%) 42.9 [37.4–49.6] 47.7 [42.0–51.9]** 49.3 [46.1–51.1] 52.5 [48.4–59.4] 44.0 [39.5–47.3] 51.2 [45.4–54.8]** 43.2 [39.3–50.6] 51.4 [46.8–54.4]**
N3 (%) 21.0 [14.3–24.3] 20.1 [16.2–24.8] 3.9 [0.6–7.4] 4.6 [0.9–13.9] 16.4 [12.8–18.8] 14.7 [10.8–17.0] 13.1 [8.6–18.1] 14.3 [11.6–15.9]
REM Sleep (%) 14.2 [10.5–16.4] 17.4 [12.7–21.1]** 16.5 [12.6–21.5] 21.8 [14.9–23.0] 20.1 [16.4–23.4] 23.7 [20.3–26.1]** 20.3 [16.6–22.5] 23.7 [21.9–26.5]**
Sleep Latency (min) 11.5 [5.5–24.0] 8.0 [4.0–18.4] 9.3 [7.0–29.0] 15.0 [9.9–21.3] 32.5 [16.9–47.1] 14.0 [10.4–20.6]** 41.0 [24.4–69.8] 18.5 [13.8–32.0]**
REM Latency (min) 96.5 [72.4–140.6] 87.5 [65.8–111.8] 125.3 [77.0–150.0] 84.0 [65.3–161.6] 83.5 [69.5–144.3] 67.0 [60.4–82.0]* 70.0 [60.5–93.3] 72.5 [60.9–84.1]
Number of Awakenings 20.0 [13.0–25.0] 20.0 [15.5–28.0] 29.0 [19.8–34.5] 19.0 [17.0–33.0] 29.0 [21.0–33.0] 25.0 [19.0–34.0] 28.0 [23.0–30.0] 27.0 [23.0–36.0]
Sleep continuity
25th percentile for duration of
continuous sleep segments (min)
1.5 [1.0–3.1] 2.3 [1.3–5.9] 1.1 [0.8–1.5] 1.5 [1.0–5.5] 2.5 [1.0–3.9] 4.5 [2.5–8.2]** 2.8 [1.9–4.3] 4.3 [2.8–7.0]*
Median duration of continuous
sleep segments (min)
6.0 [2.5–11.5] 10.5 [5.6–17.4]* 5.3 [4.5–12.8] 9.0 [4.4–20.3] 9.5 [5.5–11.9] 14.5 [9.5–20.6]** 9.5 [7.4–12.3] 12.0 [8.8–15.1]†
75th percentile for duration of
continuous sleep segments (min)
19.6 [10.8–30.8] 29.6 [19.8–37.2]* 19.9 [16.0–41.5] 28.0 [18.4–47.8] 21.0 [15.4–29.4] 28.3 [22.1–41.8]** 24.8 [18.1–29.2] 25.5 [19.9–37.9]
Sleepiness and fatigue
ESS 5.0 [3.0–7.0] 5.0 [3.0–7.0] 6.5 [5.0–8.0] 6.0 [3.3–9.5] 6.0 [3.8–7.3] 5.0 [3.0–6.3] 5.0 [3.0–7.0] 5.0 [3.0–7.0]
CFS 1.0 [0.0–3.0] 2.0 [0.0–3.0]
PVT lapses 8.8 [5.4–12.4] 9.0 [4.3–12.6] 0.8 [0.5–1.5] 0.5 [0.2–0.9] 0.7 [0.2–1.5] 0.5 [0.2–1.2]
MSLT (min) 2.5 [1.0–4.3] 2.3 [1.7–11.6]
Values are means ± SD or medians [25th percentile– 75th percentile].
**P<0.01,
*P<0.05,
†P = 0.06 for difference between S-TST and L-TST.
‡No statistical tests were performed for TST as groups were selected on the basis of TST.
https://doi.org/10.1371/journal.pone.0175504.t001
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These results held up in additional analyses using the same TST cutoff for all datasets, with
the data combined but statistically controlling for dataset and age (or age alone), as well as ana-
lyzing each dataset separately (see S2 File).
Continuity of sleep and wake
Comparisons of median, 25th percentile and 75th percentile durations of continuous sleep seg-
ments between S-TST and L-TST groups in each dataset are shown in Table 1. For dataset 1
(São Paulo controls) and the first night of dataset 3 (Healthy young adult controls), median,
25th percentile and 75th percentile durations of continuous sleep segments were significantly
shorter in S-TST than in L-TST (Table 1). For the second night of dataset 3, 25th percentile
duration of continuous sleep segments was significantly shorter in S-TST than in L-TST and
Fig 1. Distribution of total sleep time in each dataset. Distribution of total sleep time (TST) for dataset 1 (São Paulo controls), dataset 2
(Treated OSA patients) and the 1st and the 2nd nights of the dataset 3 (Healthy young adult controls). Dashed lines represent the threshold
values used to separate subjects into those with shorter TST and those with longer TST in each dataset.
https://doi.org/10.1371/journal.pone.0175504.g001
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median duration of continuous sleep segments showed a trend to being shorter in S-TST than
in L-TST, while 75th percentile duration of continuous sleep segments did not differ signifi-
cantly between S-TST and L-TST. There were no significant differences in dataset 2 (Treated
OSA patients).
Survival curves (cumulative duration distributions) of continuous sleep segments in the
whole night hypnograms of S-TST and L-TST are shown in Fig 2. For all datasets (and both
nights of dataset 3), there were significant shifts toward shorter (i.e., less continuous) bouts of
sleep in S-TST than in L-TST (Fig 2). This finding remained for dataset 1 and for both nights
of dataset 3 when restricting the analysis to the first 3 hours of the hypnograms (Fig 3).
Fig 2. Continuity of sleep for whole-night hypnograms in each dataset. Survival curves (cumulative probability distributions) of
continuous sleep segments in the S-TST (dashed, red) and L-TST (solid, blue) groups for whole-night hypnograms, for dataset 1 (São
Paulo controls), dataset 2 (Treated OSA patients) and the 1st and the 2nd nights of the dataset 3 (Healthy young adult controls) are
shown. Insets: Same but plotted semilogarithmically. The S-TST group consistently showed a significant shift toward shorter bouts of
sleep compared with the L-TST group.
https://doi.org/10.1371/journal.pone.0175504.g002
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For each dataset, the distributions of the durations of continuous sleep segments in the
whole night hypnograms appeared to be exponential, as evidenced by the linearity of the sur-
vival curves when drawn in semi-logarithmic plots (Fig 2, insets). For dataset 3, the survival
curves of continuous sleep segments for whole night hypnograms did not differ significantly
between the first and second nights (Fig 4).
Survival curves of continuous wake segments in the whole night hypnograms of S-TST and
L-TST are shown in Fig 5. For all datasets (and for both nights of dataset 3), there were signifi-
cant shifts toward longer (i.e., more continuous) bouts of wakefulness in S-TST than in L-TST.
Fig 3. Continuity of sleep for the first 3 hours of the hypnograms in each dataset. Survival curves (cumulative probability
distributions) of continuous sleep segments in the S-TST (dashed, red) and L-TST groups (solid, blue) for the first 3 hours of the
hypnograms, for dataset 1 (São Paulo controls) and the 1st and the 2nd nights of the dataset 3 (Healthy young adult controls) are shown.
The S-TST group consistently showed a significant shift toward shorter bouts of sleep compared with the L-TST group.
https://doi.org/10.1371/journal.pone.0175504.g003
Fig 4. Continuity of sleep and wake of the first and the second nights in dataset 3. Survival curves (cumulative probability
distributions) of continuous sleep segments (left) and continuous wake segments (right) for the whole-night hypnograms of the first night
(solid, black) and the second night (dashed, gray) in dataset 3 (Healthy young adult controls) are shown. Insets: Same but plotted semi-
logarithmically (left) and double-logarithmically (right). In both panels, survival curves did not differ significantly between the first and
second nights.
https://doi.org/10.1371/journal.pone.0175504.g004
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For each dataset, the durations of continuous wake segments appeared to exhibit a power-law
(or multi-exponential [43]) distribution, as evidenced by the linearity of the survival curves
when drawn in double-logarithmic plots (Fig 5, insets). For dataset 3, the survival curves of
continuous wake segments did not differ significantly between the first and second nights
(Fig 4).
These results held up in a follow-up, bootstrap-based analysis that accounted for the num-
ber of segments contributed by each subject (see S3 File). Also, the results held up in additional
analyses using the same TST cutoff for all datasets, with the data combined but statistically
controlling for dataset and age (or age alone), as well as analyzing each dataset separately (see
S2 File).
Fig 5. Continuity of wake for whole-night hypnograms in each dataset. Survival curves (cumulative probability distributions) of
continuous wake segments in the S-TST (dashed, red) and L-TST (solid, blue) groups for whole-night hypnograms, for dataset 1 (São
Paulo controls), dataset 2 (Treated OSA patients) and the 1st and the 2nd nights of the dataset 3 (Healthy young adult controls) are
shown. Insets: Same but plotted double-logarithmically. The S-TST group consistently showed a significant shift toward longer bouts of
wakefulness compared with the L-TST group.
https://doi.org/10.1371/journal.pone.0175504.g005
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Correlation between total sleep time and continuity of sleep
The relationship between TST and the median duration of continuous sleep segments is
shown in Fig 6. Across all datasets, and controlling for study, there was a significant positive
correlation between TST and median duration of continuous sleep segments (ρ = 0.35,
P<0.001). This held true for analyses controlling for age (ρ = 0.28, P<0.001), for analyses
Fig 6. Correlation between total sleep time and continuity of sleep. Scatter plots of the relationship between TST and median
duration of continuous sleep segments for dataset 1 (São Paulo controls), dataset 2 (Treated OSA patients) and the 1st and the 2nd nights
of the dataset 3 (Healthy young adult controls) are shown. Correlations were significant and positive for dataset 1 and both nights of
dataset 3 and tended to significance for dataset 2.
https://doi.org/10.1371/journal.pone.0175504.g006
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using either the first or the second night of dataset 3 (ρ = 0.35, P<0.001 and ρ = 0.34, P<0.001,
respectively) as well as for the dataset excluding subjects whose TST was less than 4 hours (ρ =
0.26, P = 0.004). Significant correlations were also found for dataset 1 and the both nights of
dataset 3 when the datasets (and the two nights of dataset 3) were analyzed separately; there
was a trend for dataset 2, which has relatively small sample size (Fig 6).
Intraclass correlation coefficients
Estimates for between-subjects and within-subjects variance and the ICC values derived from
them for the two NPSGs of dataset 3 (Healthy young adult controls) are shown in Table 2.
Using published benchmarks [44], the ICC values were ‘moderate’ for TST and median dura-
tion of continuous sleep segments. Thus, individual differences in key variables describing
sleep duration and sleep continuity were moderately stable. For TST, ICC values have been
published previously [3]; the previously reported values are very similar to those found
presently.
Measures of sleepiness and fatigue
For the three datasets, none of the subjective measures of sleepiness and fatigue (ESS and CFS
scores) nor the objective measures of sleepiness (PVT lapses and mean MSLT) differed signifi-
cantly between the S-TST and L-TST groups (Table 1).
For dataset 1 (São Paulo controls), the distribution of subjective sleep quality ratings did
not differ significantly between groups. The percentage of subjects who reported their
recorded sleep as “better” or “the same” compared to their usual sleep was 72.1% for S-TST
and 76.6% for L-TST. The percentage of subjects who reported their recorded sleep as “worse”
than their usual sleep was 27.9% for S-TST and 23.4% for L-TST.
Discussion
Interpretation of findings
We found that sleep continuity is positively correlated with objective sleep duration (TST) in
healthy controls as well as treated OSA patients. Across a wide range of naturally occurring
sleep durations in normal and corrected-to-normal (i.e., CPAP-treated) sleepers recorded
polysomnographically in the laboratory, S-TST displayed less sleep continuity than L-TST, as
evidenced by lower sleep efficiency, greater percentage of WASO and systematic differences in
survival curves indicating shorter continuous sleep segments. While systematic differences
between S-TST and L-TST in recent sleep history cannot be ruled out completely, no differ-
ences in baseline waking performance and sleepiness were observed. Taken together, these
results suggest that the S-TST phenotype may be due, at least in part, to a lower neurobiologi-
cal ability of conserving sleep continuity.
Our findings are consistent with a genetic explanation of natural sleep duration as indicated
by twin studies [4, 5], but raise questions about the role of sleep insufficiency and/or prevailing
Table 2. Intraclass correlation coefficients of sleep duration and median duration of sleep segments for dataset 3.
VARbs VARws ICC (95% CI)
Total sleep time (min) 1137.9 ± 327.0 1061.6 ± 192.2 0.52 (0.31–0.68)
Median duration of continuous sleep segments (min) 37.3 ± 10.6 33.8 ± 6.1 0.52 (0.32–0.68)
Values are means ± SD. VARbs, between-subjects variance; VARws, within-subjects variance; CI, confidence interval.
https://doi.org/10.1371/journal.pone.0175504.t002
Sleep duration and sleep continuity
PLOS ONE | https://doi.org/10.1371/journal.pone.0175504 April 10, 2017 13 / 19
sleep homeostatic pressure—suggesting instead an underlying physiological difference
between S-TST and L-TST in the stability of sleep processes. This would be consistent with a
previous study [12] showing S-TST had lower sleep efficiency and increased 24-hour urinary
norepinephrine and epinephrine levels compared to L-TST. The higher sympathetic activity
indicated by increased catecholamine levels is consistent with increased arousal, which could
in turn lead to reduced stability of sleep processes, thereby producing the S-TST phenotype.
A natural association between sleep duration and sleep continuity exists in healthy subjects
sleeping after acute total sleep deprivation; these individuals have longer and more continuous
sleep than during baseline sleep [3, 45]. Such a relationship is also seen within and between
subjects in normal aging—sleep in older people tends to be shorter and more fragmented than
in younger people [23, 24, 45, 46]. However, since there was no significant age difference
between S-TST and L-TST subjects studied here (Table 1), the relationship between sleep
duration and sleep continuity appeared to exist intrinsically. This is corroborated by the rela-
tive stability of inter-individual differences in both TST and median duration of continuous
sleep segments across the two nights of dataset 3 (Healthy young adult controls), as indicated
by moderate ICC values (Table 2).
It could thus be that S-TST may have less homeostatic sleep pressure than L-TST. However,
this conclusion seems incongruent with the idea that S-TST have greater sleep efficiency which
allows them to live under higher homeostatic sleep pressure, as has been shown in seminal
studies of specifically selected “true” extremely short and long sleepers [8, 9]. Similar to our
finding for the whole night, S-TST in our datasets (1 and 3) did not have greater sleep continu-
ity in the first 3 hours of sleep (Fig 3). These results make the explanation of greater sleep effi-
ciency in the S-TST unconvincing.
That does not necessarily mean, however, that individual differences in sleep efficiency are
entirely irrelevant in our datasets. Mechanisms underlying the existence of individual differ-
ences in sleep duration may well be multi-factorial, and which factor(s) dominate may depend
on sample selection criteria. Thus, individual differences in sleep efficiency in earlier studies
may have reflected selection bias favoring only subjects with extreme S-TST and L-TST [7–9];
such a bias did not exist in the present study where subjects were not pre-selected on the basis
of sleep duration.
Reconciliation of the seemingly competing views on the nature of S-TST and L-TST is pos-
sible with dynamic modeling. Lo and colleagues [19] introduced a dynamic stochastic model
for sleep—wake transitions in which the duration of wake bouts was simulated according to a
power-law distribution and the duration of sleep bouts was modeled according to an exponen-
tial distribution. These distributions were evident in our datasets (Figs 2 and 5). In the model,
sleep–wake state evolves over time based on a random-walk process as derived from interac-
tion between sleep-promoting and wake-promoting neuronal populations [47, 48]. In this
framework, our findings indicate that the waking pressure on the random-walk process
towards sleep is smaller in S-TST than in L-TST. In addition, S-TST need to traverse a smaller
distance in the random walk process during sleep before wakefulness is triggered. However, in
the model this distance in the random walk process during sleep does not necessarily affect
sleep depth, and in our data deep sleep (stage N3) did not differ between S-TST and L-TST. In
the context of the model, these properties are indicative of traits for overall lower homeostatic
sleep pressure and less sleep need in S-TST compared to L-TST.
Potential confounds
Various possible confounds need to be considered when interpreting our findings. These
range from the impact of outliers to first night effects, environmental factors and circadian
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timing. However, several aspects of our experimental conditions and observations make it
unlikely that these factors were influential.
In each of the three datasets, we included only subjects with no known sleep pathology.
Nonetheless, in dataset 1 (São Paulo controls), some of the subjects exhibited extremely short
sleep duration. It would be possible that these cases skewed our findings. We repeated the anal-
yses after excluding subjects whose TST values were less than 4 hours, and found that the posi-
tive correlation between sleep duration and sleep continuity persisted, indicating that our
results were not confounded by outliers. Also, the median duration of continuous sleep seg-
ments (Fig 6) was comparable to that of previously published data of healthy subjects [19], sug-
gesting that our data of sleep continuity are within the normal range. Additionally, none of the
subjects in dataset 1 took any naps prior to the study, such that short nighttime sleep duration
could not have been caused by reduced homeostatic sleep pressure due to prior napping.
In principle, a first night effect could have affected our results. Dataset 3 (Healthy young
adult controls) allowed us to rule this out, as we found no significant differences between the
first and second nights in the sleep laboratory (Table 1 and Fig 4). Further, the subjects in data-
set 2 (Treated OSA patients) had already undergone multiple PSG studies previously, making
a first night effect similarly unlikely. In dataset 1 (São Paulo controls), subjects did not undergo
multiple PSG studies, but S-TST and L-TST subjects did not differentially report their subjec-
tive sleep quality during the PSG night to be better or worse than usual. These data support
that our results were not confounded by a first night effect.
It is possible that the timing and duration of the laboratory sleep opportunities were dif-
ferent from what subjects experienced in their normal lives. Sleep opportunities in our three
datasets varied considerably, with dataset 1 providing a wide range of sleep opportunities
(between 4.5 and 10 hours TIB, starting between 21:30 and 02:30); dataset 2 providing a
more narrow range of sleep opportunities (between 7.9 and 11 hours TIB, starting between
21:00 and 00:05); and dataset 3 providing ample sleep opportunity as part of the underlying
study’s design (at least 10 hours TIB each night, starting at 22:00). Importantly, the subjects
in datasets 1 and 2 were required to abide by their habitual bedtimes and wake-up times
(which were verified by actigraphy at least 3 days before study or self-report), and the sub-
jects in dataset 3 had ample TIB which should have accommodated their habitual sleep dura-
tion (habitual sleep duration was verified by self-report and also by actigraphy in the week
before study). Since the findings of our study were consistent among the three datasets, any
explanation involving confounds owing to the timing of the laboratory sleep opportunities
therefore does not seem viable.
Lastly, subjects’ psychological status (e.g., anxiety) or extrinsic factors such as environmen-
tal disturbances (e.g., noise) could have affected our observations. However, our studies were
performed in controlled laboratory settings, and there were no differences between S-TST and
L-TST in subjective sleep quality in dataset 1 or PVT lapses in datasets 2 and 3. Moreover, the
consistency of results across the two nights in dataset 3 argues against the involvement of
extraneous, non-sleep physiological factors.
Limitations
As is true for all studies of S-TST and L-TST that are based on laboratory PSG, it is possible
that subjects displayed different sleep characteristics in the laboratory than they would at
home. While our data do not allow an assessment of this possibility, our data allowed us to at
least rule out the first night effect on polysomnographically determined sleep variables, sug-
gesting that any differences between laboratory and home sleep did not differentially affect
S-TST compared to L-TST.
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We have no objective information about the possible use of caffeine or other stimulants in
the daytime prior to the PSG study in datasets 1 (São Paulo controls) and 2 (Treated OSA
patients). Also, we have no objective information about sleep hygiene and habits in the days
prior to the PSG study in dataset 2. This could be a limitation, but the strict absence of caffeine
intake in the laboratory study of dataset 3 (which also included subjects refraining from caf-
feine intake during the 7 days before the laboratory experiment) as well as avoidance of irregu-
lar sleep hygiene and habits in datasets 1 and 3 (as evidenced by actigraphic recordings and/or
questionnaires before the study)–while yielding consistent results—argues against caffeine and
prior sleep as significant potential confounds in the study.
Another limitation is related to the different distributions and cut-off values of TST among
datasets. In fact, more than half of the L-TST in dataset 1 (São Paulo controls) could be catego-
rized as S-TST in datasets 2 (Treated OSA patients) and 3 (Healthy young adult controls). This
difference could have come from differences in age distribution, culture, life style, disease his-
tory (dataset 2), and/or experimental protocol. While we cannot determine what specifically
contributed to the observed differences in TST distributions, the consistent results within each
dataset as well as across the combined datasets controlling for study and age indicates robust-
ness and generalizability of the findings. Moreover, the consistent results of our additional
analyses using the same TST cut point, for all datasets, with the data combined but statistically
controlling for study and age, and also for each dataset separately, provide further evidence for
the generalizability of the findings.
Dichotomizing subjects into two separate groups within each dataset might be a concern, as
we observed that approximately one third of subjects in dataset 3 did not fall into the same
group across the two nights. This is largely because the threshold value of the TST split was
near the peak of the distributions (Fig 1), which maximizes the probability of crossing the
threshold between nights. However, the correlation analyses of TST as a continuous variable
against median duration of continuous sleep segments, which were not influenced by the
dichotomization, corroborated our findings, indicating that they are robust.
Finally, natural sleep duration may be a function of dynamic changes hypothesized to occur
in response to chronic sleep restriction/extension [6, 49, 50]. Subjects in dataset 3 (Healthy
young adult controls) were required to maintain their habitual sleep schedule in the week
prior to the laboratory measurements, but none of the studies we considered here measured or
controlled sleep history in the preceding months or years. It has been posited that chronic
sleep curtailment results in changes in the set point for sleep homeostasis, possibly mediated
by adenosine receptor upregulation [30, 51], which could turn natural L-TST into habitual
S-TST and vice versa while preserving normal homeostatic sleep regulation. This allostatic
mechanism would result in differential vulnerability to cognitive impairment during periods
of total sleep deprivation [6]. Further studies in moderate and extreme S-TST and L-TST mea-
suring sleep homeostatic and objective performance responses to sleep deprivation could
reveal to what extent allostatic changes induced by long-term sleep history may be involved in
determining sleep duration.
Conclusion
In conclusion, in both healthy controls and treated OSA patients, shorter total sleep times were
associated with less sleep continuity. This study covered a wide range of naturally occurring
sleep durations during normal sleep in healthy subjects and treated OSA patients (i.e., not just
extremely short and long sleepers). Our results suggest that S-TST may differ from L-TST in pro-
cesses underlying sleep continuity. This novel finding suggests a new perspective on physiologi-
cal mechanisms of sleep continuity that could lead to individual differences in sleep duration.
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